<DOC>
	<DOCNO>NCT02184858</DOCNO>
	<brief_summary>This open label 4 month study evaluate efficacy ( blood pressure lower effect ) safety lisinopril child 1-18y whose parent grant permission participate . This dose titration study conduct support statement personalize titration lisinopril ( base blood pressure renin-aldosterone ratio ) increase patient response .</brief_summary>
	<brief_title>Dose Titration Lisinopril Children Aged 1 18 Years With Primary Secondary Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Angiotensin-Converting Enzyme Inhibitors</mesh_term>
	<mesh_term>Lisinopril</mesh_term>
	<criteria>Parental consent must grant Patient age : 1y 18 Documented diagnosis hypertension define National Heart , Lung Blood Institute ( NHBLI ) 4th report , 2004 No reversible cause find diagnostic workup hypertension Children older 6y : 24h blood pressure monitoring confirm diagnosis hypertension Pregnancy Sexually active girl include trial use adequate form birth control ; 30 day end trial Following abnormal laboratory value : Hyperkaliemia ( serum potassium &gt; 5.3mmol/L ) ; Anemia ( hemoglobin &lt; 8g/dL ) ; AST ALT &gt; 3 time upper limit reference range ; Total bilirubin &gt; 3 time upper limit reference range Abnormalities oral cavity influence intake medication Known sensitivity ACEinhibitors Known lactose intolerance History angioedema Unilateral bilateral stenosis renal artery Diagnosis heart failure ( NYHA Class IIIV ) History coarctation aorta Current treatment : drug influence reninangiotensinaldosterone system ; lithium ; potassium spar diuretic ; nonsteroidal antiinflammatory drug ; aspirin ; oral antidiabetic medication</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>